BioHarvest Sciences Valuation

Is BHST undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BHST when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BHST's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BHST's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BHST?

Key metric: As BHST is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BHST. This is calculated by dividing BHST's market cap by their current revenue.
What is BHST's PS Ratio?
PS Ratio	4.8x
Sales	US$22.43m
Market Cap	US$105.32m

BHST key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5x
Enterprise Value/EBITDA	-15.7x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does BHST's PS Ratio compare to its peers?

The above table shows the PS ratio for BHST vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	9.9x
FTLF FitLife Brands	2.5x	9.2%	US$156.9m
AXIL AXIL Brands	1.1x	n/a	US$27.9m
ZHYB.F Zhong Yuan Bio-Technology Holdings	35.4x	n/a	US$88.3m
SKIN Beauty Health	0.5x	5.7%	US$176.3m
BHST BioHarvest Sciences	4.8x	66.6%	US$148.2m

Price-To-Sales vs Peers: BHST is good value based on its Price-To-Sales Ratio (4.8x) compared to the peer average (9.9x).

Price to Sales Ratio vs Industry

How does BHST's PS Ratio compare vs other companies in the US Personal Products Industry?

26 Companies	Price / Sales	Estimated Growth	Market Cap
HLF Herbalife	0.2x	1.8%	US$869.83m
NUS Nu Skin Enterprises	0.2x	-0.06%	US$375.32m
MED Medifast	0.3x	-13.4%	US$198.34m
SKIN Beauty Health	0.5x	5.7%	US$176.25m

26 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: BHST is expensive based on its Price-To-Sales Ratio (4.8x) compared to the US Personal Products industry average (1.5x).

Price to Sales Ratio vs Fair Ratio

What is BHST's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BHST PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	4.8x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate BHST's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Kimberly-Clark de México S. A. B. de C. V

Mex$85.8b

Manufactures, distributes, and sells disposable products in Mexico.

KCDM.F

Mex$1.37

-5.8%

n/a

Reynolds Consumer Products

US$5.8b

Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.

REYN

US$27.89

1.5%

7.0%

USANA Health Sciences

US$760.5m

Develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.

USNA

US$39.92

1.4%

-14.2%